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Abstract
Problem: Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal
morbidity, mortality, and postpartum readmission. Several evidence-based algorithms
and protocols have been implemented in the inpatient setting to treat severe blood
pressure and prevent complications. However, there remains an opportunity to improve
the postpartum care transition and discharge education for patients with these conditions
in an attempt to decrease 30-day postpartum hypertension readmissions.
Methods: This pilot project utilized a descriptive design and took place on a postpartum
unit at a Midwest metropolitan high-risk obstetrical teaching hospital. Interventions
included patient-specific discharge education, distribution of a home blood pressure cuff,
scheduling a blood pressure follow-up appointment prior to discharge, and a follow-up
telephone call two days after discharge. Data was collected via retrospective and
prospective electronic medical record review.
Results: The total sample size was 50 (25 retrospective and 25 prospective) participants.
Although the 30-day postpartum hypertension readmission rate did not decrease, patient
follow-up and home blood pressure monitoring increased. The follow-up telephone calls
proved to be an opportunity to address patient concerns and questions that may not have
been addressed otherwise.
Implications for Practice: Although they did not decrease the readmission rate in this
sample, improvements in discharge education, home blood pressure monitoring and the
follow-up phone calls were found to be beneficial as they led to improved patient
outcomes, readmission when indicated, and increased patient follow-up and contact with
a healthcare provider.
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Improving Postpartum Hypertension Discharge Education: A Pilot Project
In the United States, maternal mortality increased from 7.2 deaths to 16.9 deaths
per 100,000 live births from 1987 to 2016 (Centers for Disease Control and Prevention
[CDC], 2020). The CDC reports two thirds of these deaths were preventable (Williams,
2019). Hypertensive disorders of pregnancy (HDP) occur in 12-22% of pregnancies and
contribute to 17% of maternal mortalities in the United States (Williams, 2019) and 14%
of maternal mortalities globally (MacDonald, 2019). The categories of HDP are chronic
hypertension, gestational hypertension, preeclampsia, preeclampsia superimposed on
chronic hypertension, and eclampsia (Leeman et al., 2016). Preeclampsia is a
complication of pregnancy, occurring after 20 weeks gestation and characterized by newonset hypertension and proteinuria (American College of Obstetricians and
Gynecologists [ACOG], 2020). In the United States, rates of hypertension and
preeclampsia are on the rise. Between, 1987 and 2004, the rate of preeclampsia increased
by 25% (ACOG, 2020). Increased obesity rates as well as advanced maternal age
contribute to the rise in HDP (Wilkerson & Ogunbodede, 2019), yet preeclampsia can
occur in patients who do not have risk factors (ACOG, 2020).
Hypertensive disorders were the number one cause of postpartum readmission in
a multi-state analysis of postpartum readmissions in the United States from 2004 to 2011
(Clapp et al., 2016). Hospital readmissions are associated with increased healthcare costs
and decreased quality of life for patients and their families. Maternal blood pressure
peaks three to six days postpartum, after most patients have been discharged (O’Meara &
Lepic, 2016), and preeclampsia and its complications can occur as late as six weeks after
delivery (Drews & Tsigas, 2013). Risk factors for late postpartum preeclampsia include
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advanced maternal age, black race, Latino ethnicity, obesity, and gestational diabetes
mellitus (Bigelow et al., 2014). Hypertensive disorders of pregnancy can often be
managed in the outpatient setting if there is no evidence of preeclampsia with severe
features. Severe features include blood pressure greater than 160 mm Hg systolic or 110
mm Hg diastolic, proteinuria, elevated liver enzymes, decreased platelets, pulmonary
edema, visual or cerebral disturbances, and severe persistent right upper quadrant
abdominal pain (ACOG, 2020). Early recognition and prompt treatment of postpartum
preeclampsia is critical to prevent complications such as eclamptic seizures, stroke,
pulmonary edema, thromboembolism, or death (Andrus & Wolfson, 2010).
Several evidence-based algorithms and protocols have been implemented in the
inpatient setting to promptly treat preeclampsia and severe blood pressures. There
remains an opportunity to improve the postpartum care transition and discharge education
for patients with HDP. The purpose of this clinical scholarship project was to decrease
postpartum hypertension 30-day readmissions by improving patient education, providing
home blood pressure cuffs, conducting follow-up phone calls, and promoting patient
adherence to medications, follow-up, and home blood pressure monitoring. Patient
education focused on adherence to antihypertensive medications and follow-up, home
blood pressure monitoring, and early identification of symptoms of hypertension and
preeclampsia for which to notify a healthcare provider. The evidence-based practice
framework guiding this pilot project was the Iowa Model. The aim of the project was to
decrease 30-day postpartum hospital readmissions for patients with HDP by 10% at a
Midwestern metropolitan high-risk obstetrical hospital. The primary outcome measure
was the 30-day postpartum HDP readmission rate. Secondary outcome measures were
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whether the participant went to their follow-up blood pressure check appointment,
whether the participant was monitoring their blood pressure at home, whether the
provider noted the participant was monitoring their blood pressure at home in the followup appointment progress note, and patient demographic information including age, race,
and insurance status. The study question was: In postpartum patients aged 18 and older
with HDP, what are the effects of improved HDP discharge education and selfmanagement resources on the 30-day postpartum HDP readmission rate over two
months?
Review of the Literature
The literature review process involved extensive review of the following scholarly
databases and search engines: PubMed, CINAHL, Academic Search Complete, and the
University of Missouri – St. Louis Library Summons search engine. The following search
terms and phrases were used: preeclampsia, postpartum preeclampsia, maternal
hypertension, postpartum hypertension, preeclampsia follow-up, postpartum
readmission, maternal hypertension readmission, postpartum preeclampsia readmission,
maternal mortality, hypertensive disorders of pregnancy, postpartum education,
postpartum preeclampsia management, and home blood pressure monitoring. The
Boolean operators AND and OR were used to refine search results. Inclusion criteria
were scholarly and peer-reviewed publications, year 2010 to present, and English
language. Exclusion criteria were studies or research prior to the year 2010, publications
from other countries, except for the United Kingdom and Australia, and publications in
any other language except English. Use of the ancestry method generated four references.
The final number of publications selected for this literature review was 13.

IMPROVING POSTPARTUM HYPERTENSION DISCHARGE

6

This literature review discusses interventions to improve patient HDP discharge
education, quality of care, and transition of care to ultimately decrease postpartum HDP
readmissions. There are a significant number of evidence-based recommendations
regarding HDP screening and treatment, but there is limited research addressing clinical
interventions to prevent and reduce postpartum hypertension readmissions associated
with HDP (O’Meara & Lepic, 2016). One meta-analysis concluded that provider and
patient education, verbal and printed resources, prompt post-discharge follow-up, text
message and telephone follow-up, and postnatal furosemide possess the potential to
decrease postpartum HDP readmissions and associated morbidity and mortality (O’Meara
& Lepic, 2016). Additional recommendations for improving care for postpartum patients
with preeclampsia include improved patient education, teach-back methods, scheduling a
postpartum blood pressure check appointment prior to discharge, and home blood
pressure monitoring (Drews & Tsigas, 2013).
Patient education is crucial to improving awareness, recognition, and treatment of
postpartum HDP. Among nurses providing patient education there are wide variations in
how much discharge education is done and which maternal warning signs are reviewed
with patients (Suplee et al., 2016). Implementation of standardized education better
equips patients to recognize health changes and warning signs and is an important
component in decreasing maternal morbidity and mortality (Suplee et al., 2016). To
benefit from evidence-based management strategies for HDP, patients must be able to
recognize the signs and symptoms of preeclampsia and hypertension and know when to
seek medical care (Drews & Tsigas, 2013). The Missouri Alliance for Innovation on
Maternal Health initiative recommends that every pregnant and postpartum patient be
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provided standardized education on the signs and symptoms of hypertension and
preeclampsia, including when to seek medical care and what symptoms to report to
providers (Williams, 2019). The American College of Obstetricians and Gynecologists
(ACOG) Task Force on Hypertension in Pregnancy (2013) recommends that postpartum
discharge instructions include information about the signs and symptoms of preeclampsia
and the urgency of reporting these symptoms to a health care provider. The Joint
Commission (2019) recommends that printed education detailing the signs and symptoms
of HDP during hospitalization, the signs and symptoms of HDP post-discharge that
require immediate care, and when to follow-up, be provided to all patients and their
families or partners.
The manner and method in which patient education is provided is important. The
California Maternal Quality Care Collaborative (2013; with permission from The
Preeclampsia Foundation) published a discharge handout for patients with a diagnosis of
preeclampsia. The discharge handout lists patient-specific antihypertensive medications
and frequency of administration, the follow-up appointment date and time, and the signs,
symptoms, and blood pressure readings that warrant healthcare provider notification
(California Maternal Quality Care Collaborative, 2013). Individualized discharge
instructions benefit patients and their families by providing patient-specific instructions.
Postpartum patients who are unable to recognize the signs and symptoms of
hypertension or preeclampsia and do not seek medical care, are at risk for severe
morbidity and mortality as a result of untreated preeclampsia. Most patients presenting
with postpartum eclampsia or stroke experienced preeclampsia symptoms for hours or
days before the disease process worsened (ACOG, 2020). Without education, new
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mothers may unknowingly presume symptoms are normal in the postpartum period
(Drews & Tsigas, 2013). Another important component of preeclampsia discharge
education is ensuring patients know where to seek care and to notify all healthcare
providers that they have recently given birth, since hypertension parameters and
treatments are significantly different between the general adult population and
postpartum patients.
Antihypertensive medications are an important component of postpartum HDP
management. The American College of Obstetricians and Gynecologists recommend
postpartum patients with a HDP be prescribed a long-acting oral antihypertensive until
gestational hypertension resolves (Sharma & Kilpatrick, 2017). A systematic review
concluded that the use of antihypertensive medications in pregnant women halved the
risk of developing severe hypertension but had little to no effect on developing
preeclampsia (Abalos et al., 2018). A study evaluating the effectiveness of a postpartum
care transition clinic for HDP concluded that patient incomprehension and
noncompliance with discharge medications require universal efforts to improve
postpartum care and education for this high-risk group of patients (Celi et al., 2019),
indicating an opportunity to improve patient education about antihypertensive
medications.
A timely post-discharge follow-up appointment for blood pressure monitoring is
important for early identification of postpartum HDP and to screen patients for
symptoms. There are clear recommendations on prenatal appointment frequencies, yet
there is a lack of consensus on when and how often postpartum follow-up appointments
for HDP should occur. A single blood pressure follow-up appointment may be
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inadequate to detect postpartum HDP exacerbations. The American College of
Obstetricians and Gynecologists (2013) recommends postpartum blood pressure
surveillance for at least 72 hours (inpatient or equivalent outpatient surveillance) after
delivery and again seven to 10 days postpartum, or earlier if symptoms are present. The
Society for Maternal-Fetal Medicine recommends a postpartum appointment within 72
hours for patients with severe hypertension and an office visit within one to three weeks
for all patients with HDP (Patient Safety and Quality Committee et al., 2020). The
California Maternal Quality Care Collaborative recommends follow-up appointments be
scheduled prior to discharge (Drews & Tsigas, 2013).
Home blood pressure monitoring in the postpartum period can result in early
identification of postpartum HDP. The California Maternal Quality Care Collaborative
recommends that patients with a history of preeclampsia monitor their blood pressure at
home with instructions to call their provider if pressures reach or exceed 140/90 (Drews
& Tsigas, 2013). The Society for Maternal-Fetal Medicine recommends patients with
HDP monitor blood pressure at home until the follow-up visit seven to 10 days
postpartum (Patient Safety and Quality Committee et al., 2020). Barriers to home blood
pressure monitoring include the cost of equipment, insurance coverage of equipment,
correct use of equipment, and patient understanding and ability to identify elevated blood
pressures that require treatment. The American Heart Association (2020) published a
patient education handout that illustrates the correct procedures for patient blood pressure
monitoring.
Post-discharge telephone calls are an effective intervention to improve postpartum
HDP transition of care. Patient reminders, such as telephone calls or text messages, have
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been associated with increased patient appointment adherence (Williams, 2019). A study
evaluating hospital discharge phone calls concluded that they are a valuable tool to
improve the quality and continuity of care after discharge and reduce preventable
readmissions (Schuller et al., 2017).
The goals of postpartum management of HDP are to educate patients about the
importance of taking antihypertensive medications as prescribed to prevent hypertensive
crises, encourage home blood pressure monitoring and follow-up, and provide education
about the symptoms and blood pressure readings to notify a provider so patients can seek
care sooner rather than later, potentially avoid hospitalization, and decrease the risk of
life-threatening complications.
Methods
The Iowa Model was selected to guide this project because of its applicability in
implementing evidence-based practice (Dang et al., 2019). The Iowa Model provides a
step-by-step process to implementing evidence-based practice and includes opportunities
to evaluate and redesign as needed (Dang et al., 2019). Upon completion of the project
and data analysis, a decision was made regarding the appropriateness of adopting the
interventions into routine practice (Dang et al., 2019).
An opportunity to improve patient HDP education on an inpatient postpartum
hospital unit was identified. Prior to project implementation, the unit utilized two
evidence-based recommendations to decrease readmissions, including general follow-up
phone calls on all discharged patients approximately 48 hours after discharge and a
discharge education handout that lists symptoms to notify a healthcare provider of. The
education handout was not patient or hypertension specific, and the follow-up telephone
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call script did not include questions regarding blood pressure or hypertension symptoms.
Discharge instructions were lengthy, in small print, and generally not patient specific.
The goals of this project were to improve patient self-management, home blood
pressure monitoring, follow-up, and the early identification of elevated blood pressures
and symptoms of preeclampsia so that patients could seek medical care and management
in the outpatient setting when appropriate and prevent both readmission and lifethreatening complications. The evidence-based practice recommendations implemented
in this project were: individualized verbal and written patient-specific education about
medications, follow-up, symptoms to report and seek emergent care for, and how to
monitor blood pressure at home; distribution of a blood pressure cuff to participants who
did not have a functioning blood pressure cuff for home use; distribution of a blood
pressure documentation log that participants were encouraged to use and bring to their
follow-up appointment; and a follow-up telephone call two days after discharge to screen
for symptoms, ensure prescription medications were obtained and being taken as
prescribed, discuss blood pressure readings and encourage participants to monitor blood
pressure if they had not been, ensure follow-up appointment was scheduled, and remind
the participant of the importance of attending the appointment. These interventions were
cost-effective and did not require extensive patient resources, an important element for a
patient population that is affected by social determinants of health and limited resources.
The retrospective and prospective 30-day HDP readmission rates were compared to
determine whether or not these practice changes were beneficial.
Design
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This pilot project utilized a descriptive design and involved retrospective and
prospective electronic medical record reviews.
Setting
The project took place in a 28-bed postpartum mother-baby unit in a 584-bed
high-risk obstetrical nonprofit teaching hospital in a Midwest metropolitan area of
approximately 2.8 million residents. The unit staff was comprised of approximately 68
staff nurses and approximately 50 women’s healthcare providers, including resident,
fellow, and attending physicians and advanced practice nurses. In 2021, there were 2,545
delivering obstetric patients at this facility. The majority of obstetric patients are ages 2130, Medicaid participants, and black race. Hypertension or preeclampsia account for 8090% of postpartum readmissions at this facility. There is an average of 83 pregnant or
postpartum patients per month with at least one severe range blood pressure episode
(Meyer & Wilson-Griffin, n.d.).
Sample
The target population was a convenience sample of adult inpatient postpartum
females aged 18 and older who had a current diagnosis of preeclampsia or gestational
hypertension, were admitted on the postpartum unit, and were a patient of an in-network
provider, so that documentation of the follow-up appointment could be accessed via the
electronic medical record. Exclusion criteria were patients with a primary language other
than English due to the lack of educational materials in other languages at this time,
patients younger than age 18, and patients who received care from an obstetric provider
outside of the healthcare network, due to the inability to access electronic medical record
documentation of the follow-up blood pressure check follow-up appointment. The total
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sample size was 50 participants: 25 retrospective and 25 prospective participants. Eligible
prospective participants were identified by the primary investigator via daily reviews of
the unit census. Retrospective participants were selected using a random sample
generator from an electronic medical record report of patients meeting inclusion criteria
who were discharged in the two month period immediately prior to project
implementation.
Approval Process
Approval from the primary investigator’s Doctor of Nursing Practice committee,
the University of Missouri-St. Louis’ graduate school and institutional review board
(IRB), hospital unit leadership, and healthcare institution IRB were obtained prior to
project implementation and data collection. A risk of this project was the identification of
participants, yet this risk was minimized because the only patient identifiers collected
were the medical record number (MRN) and patient’s telephone number. All patient
identifiers on data collection tools were removed upon completion of prospective data
collection. Informed consent documents containing the participant’s name were kept in a
locked cabinet behind a locked door on a locked unit in the healthcare facility. The data
collection spreadsheet was a password-protected document on a password-protected
computer that only the primary investigator had access to. Retrospective and prospective
medical record reviews and participation in one-to-one provider-to-patient education
posed minimal risk to participants.
Data Collection/Analysis
Pre-implementation retrospective data was collected via electronic medical record
review and included: participant demographic information (age, race, and insurance
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status), participant’s HDP diagnosis (gestational hypertension and/or preeclampsia), date
of discharge, whether the participant attended the blood pressure follow-up appointment,
whether there was documentation in the follow-up appointment progress note that the
participant was monitoring their blood pressure at home, whether a 30-day readmission
occurred, and the cause of readmission. Prospective data collection occurred 31 days after
patient discharge to identify if a hypertension-related readmission occurred. Prospective
data was collected via electronic medical record review and included: participant MRN,
participant telephone number, participant demographic information (age, race, and
insurance status), whether a blood pressure cuff was given or the participant already had
access to one, the date of discharge, participant HDP diagnoses, follow-up phone call
date and information (whether the participant was currently monitoring blood pressure,
was reminded to monitor blood pressure, or was unable to be reached in three telephone
call attempts), whether the participant went to their blood pressure follow-up
appointment, whether there was documentation in the follow-up appointment progress
note that the participant was monitoring their blood pressure at home, whether or not a
readmission occurred, and the cause of readmission.
Data analysis consisted of descriptive and inferential statistics and was completed
using Intellectus Statistics (2021). The Fischer’s exact test was utilized to determine
whether a correlation between improvements in discharge education and readmission
rates existed. A Fisher’s exact test analyzes the relationship between two nominal
variables (Intellectus Statistics, 2021).
Procedures
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The primary investigator (a staff registered nurse on the unit) met with the
interdisciplinary team, including the perinatal quality coordinator, postpartum nurse
manager, and a high-risk obstetrical nurse practitioner. Patient educational tools and the
informed consent were developed by the primary investigator. Permission was obtained
from the American Heart Association (2020) to use their How to Get Your Blood
Pressure Checked patient education illustration. All aforementioned approvals to conduct
the pilot project were obtained. Project implementation occurred over a two-month
period. Eligible patients, based on inclusion and exclusion criteria, were approached
about the project and informed consent was obtained if the patient opted to participate.
The primary investigator counseled the participants, administered the discharge
education, and individualized the education materials by adding the patient’s specific
medications, OB/GYN provider contact information, and follow-up appointment date and
time. The primary investigator distributed a home blood pressure monitor to the
participant if they did not have access to one at the time of discharge, along with a blood
pressure documentation log, and reviewed how to correctly and accurately measure one’s
blood pressure and when to notify the provider of elevated or exceptionally low blood
pressure measurements. The participants were instructed to bring the blood pressure log
to their follow-up appointments. The primary investigator conducted the follow-up
telephone call with participants two days after hospital discharge and discussed the
routine postpartum follow-up telephone call questions, in addition to reviewing the
participant’s blood pressure readings since discharge, reviewing medications and
inquiring whether they were obtained and being taken as prescribed, screening the
participant for signs and symptoms of preeclampsia and hypertension, ensuring a follow-
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up appointment was obtained and reminding the participant of the appointment, and
addressing participant questions and concerns. The primary investigator reviewed the
electronic medical records of study participants 31 days after discharge to identify if the
participant went to their blood pressure follow-up appointment, if there was
documentation in the follow-up appointment progress note that the patient was
monitoring their blood pressure at home, whether a 30-day HDP readmission occurred,
and the cause of readmission. Pre-intervention retrospective data was collected via
electronic medical record review. Data was analyzed. Retrospective and prospective
readmission rates, home blood pressure monitoring, and follow-up appointment
attendance rates were compared.
Results
A total of 25 retrospective electronic medical record reviews (Nr= 25) were
conducted and a total of 25 participants (Np = 25) made up the prospective sample for a
total sample size of 50 (N=50). In both the retrospective and prospective samples, the
most common HDP diagnosis was preeclampsia (nr=13, 52%; np =18, 72%), followed by
gestational hypertension (nr=12, 48%; np=7, 28%). In both samples, the most common
age range was 18-29 (nr=15, 60%; np=14, 56%), followed by ages 30-39 (nr=8, 32%;
np=10, 40%), and age 40 and older (nr=2, 8%; np=1, 4%). The predominant race was
black (nr=17, 68%; np=22, 88%), followed by white (nr=8, 32%; np=3, 12%). The
majority of patients had Medicare insurance coverage (nr=15, 60%; np=19, 76%),
followed by private health insurance (nr=10, 40%; np=6, 24%).
Twenty blood pressure cuffs were administered during project implementation;
five patients already had access to a home blood pressure cuff. The follow-up phone calls
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revealed that the majority of patients who received the postpartum hypertension
education were monitoring their blood pressure at home (np=19, 76%). Three participants
(np=3, 12%) had not yet monitored their blood pressure at home and three participants
(np=3, 12%) were unable to be reached after three phone call attempts. More patients in
the prospective sample (np=17, 68%) went to their blood pressure follow-up appointment
than in the retrospective sample (nr=13, 52%). Three participants in the prospective
sample ended up following-up with a provider outside of the healthcare network so their
appointment documentation was unable to be viewed. An increased number of patients
were noted to be monitoring their blood pressure at home in the follow-up appointment
progress note in the prospective sample (np=8, 32%) than the retrospective sample (nr=7,
28%). The retrospective sample had a 12% (nr=3) all-cause 30-day readmission rate and
zero HDP-related readmissions (nr=0, 0%). The prospective sample had a lower
readmission rate at 8% (np=2). However, both readmissions (np=2, 8%) were
hypertension related.
A Fischer’s exact test was conducted to determine whether there was a correlation
between the improved postpartum HDP discharge education and the number of
hypertension-related readmissions (see Table 2). The results of this test were not
significant based on an alpha value of 0.05, OR=0.00, p = 0.490. The postpartum HDP
discharge education was not associated with a decrease in hypertension-related
readmissions. A second Fischer’s exact test was conducted to determine whether there
was a correlation between the improved postpartum HDP discharge education and
patients attending their blood pressure follow-up appointment (see Table 3). The results
were significant based on an alpha value of 0.05, p = 0.041, suggesting there is a
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correlation between the improved education and patient follow-up. A third Fischer’s
exact test was conducted to determine whether a correlation existed between HDP
diagnosis and 30-day readmission (see Table 4). The findings were not significant based
on a alpha value of 0.05, p = 0.140, suggesting there is not a correlation between these
two variables.
Discussion
In regard to the purpose and aim of the study, the 30-day postpartum HDP
readmission rate was not decreased as intended. Regarding the study question, improved
HDP education and self-management resources for postpartum patients with HDP did not
result in decreased postpartum 30-day HDP readmissions in this study. A possible
explanation is that because of the study interventions, the patients identified symptoms or
blood pressure readings that warranted emergency intervention and presented to the
hospital as instructed. Although the readmission rate did not decrease, the study was
clinically significant because there was improved patient education and transition of care.
One of the prospective sample participants with a HDP readmission identified
elevated blood pressure one day after discharge while monitoring her blood pressure with
the administered blood pressure cuff and then presented to the hospital Women’s
Evaluation Unit. As reviewed during the discharge education intervention, the participant
identified a severe blood pressure reading and took the appropriate action. The second
prospective sample participant with a HDP readmission had not yet monitored her blood
pressure at the time of the follow-up telephone call and was therefore reminded to during
the call, screened for HDP warning signs, and reminded to attend follow-up appointment.
This participant did attend her blood pressure follow-up appointment where elevated
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blood pressures were identified, and she was instructed to present to the hospital for
monitoring.
There was a significant increase (52% to 68%) in postpartum blood pressure
follow-up rate between the retrospective and prospective samples and an increase (28%
to 32%) in the number of patients noted to be monitoring their blood pressure at home in
the provider’s follow-up appointment documentation. In the prospective sample, 76% of
participants were monitoring their blood pressure at home at the time of the follow-up
phone call. It is unknown how many patients were monitoring their blood pressure at
home in retrospective sample, because that information is not documented as part of the
routine follow-up telephone calls. Two participants were both unable to be reached by
telephone and did not attend their follow-up appointment. Three participants did not
attend their follow-up appointment but were reached by telephone, in which they were
screened for symptoms, reviewed recent blood pressure readings with the primary
investigator, and reminded to take medications as prescribed. Merely telephone follow-up
with a registered nurse is preferred to no follow-up with a healthcare provider.
During the majority of telephone calls, participants had additional questions or
concerns that the primary investigator was able to address. During a few calls, the
participant had already missed their follow-up appointment or notified the primary
investigator they were unable to keep the appointment. In these cases, the primary
investigator assisted the patients in rescheduling. A few participants reported they had not
yet picked up their prescription antihypertensive medications from the pharmacy. The
telephone calls became an opportunity for the primary investigator to reinforce education
on the importance of medication management for HDP and encourage the participants to
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obtain the medications. Lastly, one participant expressed concern about her infant during
the telephone conversation. The conversation resulted in the primary investigator
recommending the participant to take her infant to the emergency department due to
concern for infection. The follow-up telephone calls were found to be beneficial in the
postpartum period as an opportunity to screen for HDP symptoms, discuss blood pressure
readings, ensure medications were obtained and being taken as prescribed, ensure followup was obtained, and address patient questions and concerns.
The demographics of the study sample were representative of the unit’s general
patient population. Of the two readmitted participants in the prospective sample, there
was no correlation between demographics. One participant was greater than or equal to
age 40, white race, had private insurance coverage, and was routinely monitoring her
blood pressures after discharge. The second participant was age 18-29 age group, black
race, had Medicaid insurance coverage, and had not yet monitored her blood pressure at
the time of the follow-up phone call. Both participants went to their blood pressure
follow-up appointment. This suggests that postpartum HDP discharge education and
transition of care should be universal and not directed at specific demographics.
Readmissions may not have been the optimal primary outcome measure for this
project. In this instance, the increase in readmissions was a positive outcome as the
participants sought care in a timely manner and avoided emergency transportation, an
intensive care unit admission, and death. Although decreasing readmissions is important,
contact with a healthcare provider during the follow-up phone call and follow-up
appointment, and the ability to monitor blood pressures at home made a significant
difference in improving the care and outcomes for the participants. Episodes of contact
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with a healthcare provider may have been a more appropriate primary outcome measure
for this pilot project.
Strengths of this study include interventions that were evidence-based and
minimal variation in education and telephone calls, as all interventions were completed
by the primary investigator. Potential weaknesses were the small sample size, short
timeline, and the three participants in the prospective sample whose follow-up
appointment documentation was unable to be viewed due to following-up with a provider
outside of the healthcare network. Although the goal was to obtain an appointment prior
to discharge, this was not always possible when patients were discharged on the weekend
and offices were closed. These three participants notified the primary investigator during
the follow-up telephone call that they were going to follow-up with an out-of-network
provider they had previously seen and was more convenient.
Recommendations for further research include a larger sample size and timeline,
implementing similar interventions in the antepartum period, and modifying the primary
outcome measure. Implications for practice include patient-specific discharge education,
standardizing HDP education in the antepartum and postpartum period among all
maternal health providers and nursing staff, post-discharge telephone calls, home blood
pressure monitoring in the postpartum period for high-risk patients, improving access to
and insurance coverage of home blood pressure cuffs, and utilizing telehealth for
postpartum follow-up.
Conclusion
The goal of this pilot project was to improve HDP discharge education, follow-up,
and patient self-management to decrease 30-day HDP readmissions on an inpatient
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postpartum unit. The evidence-based practice recommendations implemented in this
project were: individualized verbal and written patient-specific education about
medications, follow-up, symptoms to report and seek emergent care for, and how to
monitor blood pressure at home; distribution of a blood pressure cuff to participants who
did not have a functioning blood pressure cuff for home use; distribution of a blood
pressure documentation log that participants were encouraged to use and bring to their
follow-up appointment; and a follow-up telephone call two days after discharge to screen
for symptoms, ensure prescription medications were obtained and being taken as
prescribed, discuss blood pressure readings and encourage participants to monitor blood
pressure if they had not been, ensure a follow-up appointment was scheduled, and remind
the participant of the importance of attending the appointment. The retrospective and
prospective 30-day HDP readmission, follow-up appointment, and home blood pressure
monitoring rates were compared to determine whether these practice changes were
beneficial.
Although there was an increase in the 30-day HDP readmission rate between the
retrospective and prospective samples, there was a significant increase in patient followup and a significant portion of participants who adhered to home blood pressure
monitoring. The follow-up telephone calls were found to be beneficial in reinforcing
education and addressing patient concerns. Regardless of their effect on readmission
rates, improvements in postpartum education, follow-up, and transition of care for
patients with a diagnosis of HDP improved patient outcomes by promoting early
identification of warning signs and prompting patients to seek appropriate care.
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Table 1
Frequency Table of Diagnosis and Demographic Information of Study Participants
_______________________________________________________________________
Sample
Variable
Retrospective
Prospective____
n
%
n
%___
HDP Diagnosis
Gestational hypertension

12

48

7

28

Preeclampsia

13

52

18

72

18-29

15

60

14

56

30-39

8

32

10

40

≥ 40

2

8

1

4

Black

17

68

22

88

White

8

32

3

12

Medicaid

15

60

19

76

Private

10

40

6

24

Age

Race

Insurance

________________________________________________________________________
Note. N = 50. (n = 25 for each sample).
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Figure 1
Comparison of Retrospective and Prospective Outcome Measures
19

20
17

18
16
13

Frequency

14
12
10

7

8

8

6
4

3

2

2

2
0

0
30-day
readmission

30-day HDP
readmission

Went to blood
Provider
pressure follow-up documented
appt
patient monitoring
blood pressure at
home at follow-up
Outcome Measures
appt

Retrospective

Home blood
pressure
monitoring

Prospective

Note. N = 50 (n = 25 for each sample). Unknown frequency for home blood pressure
monitoring in retrospective sample.
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Table 2
Fischer Exact Test of 30-day HDP Readmissions among Retrospective versus
Prospective Samples
Sample
30-day HDP Readmission
Yes
No

Retrospective Prospective
0 [1.00]
2 [1.00]
25 [24.00]

Note. N = 50. Values formatted as Observed [Expected].

23 [24.00]

OR
0.00

p
0.490
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Table 3
Fischer Exact Test of Blood Pressure Follow-up Appointments among Retrospective
versus
Prospective Sample
Sample
Went to Blood Pressure Follow-up Appt
Yes
No
Unable to view

Retrospective
13 [15.00]

Prospective
17 [15.00]

12 [15.00]

5 [8.50]

0 [1.50]

3 [1.50]

Note. N = 50. Values formatted as Observed [Expected].

p
0.041
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Table 4
Fischer Exact Test of HDP Diagnosis and 30-day HDP Readmission
HDP Diagnosis

Yes

0 [1.24]

Gestational
Hypertension
2 [0.76]

No

31 [29.76]

17 [18.24]

30-day HDP Readmission

Preeclampsia

Note. Values formatted as Observed [Expected]. N = 50.

p
0.140

